FIELD: medicine; cardiology and endocrinology.
SUBSTANCE: thromboplastin formation normalisation in patients suffering from metabolic syndrome (MS) is ensured with four-month hypo-calorie diet, graduated static and dynamic physical activity, preparations dosed 30 mg once a day and Lozartan dosed 50 mg once a day.
EFFECT: normalisation of thromboplastin formation activity and time in patients suffering from MS.
1 ex
Authors
Dates
2009-02-10—Published
2007-06-19—Filed